Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cysts
NCT02261896Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Oct 2014
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ciprofloxacin in bacterial infection (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Risk of infection of a pancreatic cyst or infection related to the procedure at 21 days. Started Oct 2014; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02261896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02261896.